Search filters

List of works by Herbert Y. Meltzer

5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.

scientific article published on 15 March 2017

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

scientific article published in November 2002

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

scientific article

A genome-wide investigation of SNPs and CNVs in schizophrenia

scientific article

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

scientific article

A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells

scientific article

A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia

scientific article

A within-subject consideration of the psychotic spectrum disorder concept in a patient in remission associated with cortical gray matter recovery

scientific article published on 01 July 2018

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

scientific article published on 16 January 2019

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

scientific article

An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus

scientific article

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

scientific article published on 23 May 2017

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

scientific article

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

scientific article published on 23 April 2020

Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia ⬇️

scientific article published on 05 May 2011

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

scientific article published in February 2013

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

scientific article published on 8 October 2015

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

scientific article published in July 1999

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

scientific article published in July 2009

Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia

scientific article

Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia

scientific article published in November 2005

Association study between the neurexin-1 gene and tardive dyskinesia

scientific article published in January 2017

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

scientific article published on 2 February 2012

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

scientific article published in August 2005

Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs.

scientific article published on 24 July 2010

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

scientific article published on 15 August 2018

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

scientific article published in February 2015

Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies

scientific article published on 22 June 2012

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response

scientific article published on 26 May 2008

Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response

scientific article published on 8 November 2006

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

scientific article published on 20 August 2010

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

scientific article published in April 2010

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

scientific article published on 7 September 2006

Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians

scientific article published on 3 June 2010

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia

scientific article published on 13 August 2009

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

scientific article

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

scientific article published in March 2002

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

scientific article published on 8 January 2016

Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt

scientific article

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

scientific article published on 28 April 2005

Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data

scientific article

Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia

Dopamine D2 receptor gene variants and quantitative measures of positive and negative symptom response following clozapine treatment

scientific article published on 8 November 2005

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration

scientific article published on 8 December 2011

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response

scientific article

Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia

scientific article

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

scientific article

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

scientific article

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication

scientific article published on 24 August 2006

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

scientific article published on 30 January 2014

Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial

scientific article published on February 2010

Finite mixture regression model analysis on antipsychotics induced weight gain: investigation of the role of the serotonergic genes

scientific article published on 26 July 2012

Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U.

scientific article

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

scientific article published on 15 February 2016

Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia

scientific article published on 18 January 2006

Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.

scientific article

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain

scientific article published on 8 August 2011

Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes

scientific article published on 18 April 2017

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

scientific article published on 13 February 2009

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

scientific article published on 5 October 2008

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

scientific article

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

scientific article published on 18 September 2018

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

scientific article

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

scientific article published in March 2014

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans

scientific article published on 22 August 2019

Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

scientific article published on 6 April 2010

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

scientific article

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

scientific article published in October 2007

Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.

scientific article published on 23 January 2015

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

scientific article published on 18 November 2016

In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems

scientific article published on January 2008

Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response.

scientific article published on 22 September 2010

Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia

scientific article published in April 2010

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

scientific article published on January 2015

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

scientific article published on 24 February 2014

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

article

It is time to take a stand for medical research and against terrorism targeting medical scientists

scientific article

Lack of association between HTR4 gene polymorphisms and schizophrenia in case-control and family-based samples

scientific article published on 05 November 2009

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

scientific article published in March 2001

Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects

scientific article published in December 2009

Lack of association of NALCN genetic variants with schizophrenia

scientific article published on 31 July 2010

Liver enzyme CYP2D6 gene and tardive dyskinesia

scientific article published on 24 September 2020

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs

scientific article published on 02 December 2013

MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis

scientific article published on 17 March 2009

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach

scientific article published on 30 May 2019

No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia

scientific article published in August 2004

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

scientific article

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

scientific article published on 22 September 2009

PM389. Preliminary Genetic Model Predicting Clozapine Response.

scientific article published on 27 May 2016

Pathway-based analysis of GWAS datasets: effective but caution required ⬇️

scientific article published on December 16, 2010

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine

scientific article

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

scientific article

Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia

scientific article published in September 2010

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

scientific article published in November 2010

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response

scientific article published on 15 December 2015

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective

scientific article published in January 2011

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

scientific article published on 16 April 2014

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

scientific article

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?

scientific article

SU3. Preliminary Study for Association of Genome-Wide Significant Glutamate Receptor Schizophrenia Risk Variants With Clozapine Response.

scientific article

Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes

scientific article published on 3 March 2010

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia

scientific article published on 11 May 2020

Subchronic phencyclidine treatment in adult mice increases GABAergic transmission and LTP threshold in the hippocampus.

scientific article

Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia

scientific article published on 14 April 2005

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report

scientific article published on 13 July 2010

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement

scientific article published on August 2010

Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia ⬇️

scientific article published on June 24, 2012

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2.

scientific article published in April 2018

The catechol-O-methyl-transferase gene in tardive dyskinesia

scientific article published in September 2010

The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia

scientific article published on 06 November 2019

The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?

scientific article

The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux

scientific article published on 12 October 2007

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response

scientific article published on 3 September 2011

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

scientific article published on 27 May 2012

The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain

scientific article published in January 2015

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

scientific article published on 6 December 2016

Variants in the oxytocin gene and risk for schizophrenia

scientific article published on 23 May 2010

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity

scientific article published on 12 October 2006

Ziprasidone : a viewpoint by herbert y. Meltzer

scientific article published on 01 August 1997

Paulina is supported by:

About Paulina

Help